Hospice Shown to Save Costs, Reduce Emotional Distress for Terminally Ill

News Type:
News Article
Article:
Hospice Shown to Save Costs, Reduce Emotional Distress for Terminally Ill
September 29, 2010
Issue Areas:
A study done by the Yale School of Public Health and Mount Sinai School of Medicine, found the cost of care for cancer patients who prematurely stopped hospice care was nearly five times higher than those who continued such care. Patients who stayed in hospice care incurred $6,537 in expenses from the time of hospice to death, compared to $30,848 incurred expenses for those who stopped hospice. Data from more than 90,000 cancer patients revealed that patients who stopped hospice not only had considerably higher health care use and costs but also were more likely to be hospitalized or need emergency department care. On average, a former hospice patient spent 19.3 days in a hospital, while patients who continued hospice care spent an average of 6.7 days in the hospital. Additionally, the Dana-Farber Cancer Institute found that patients with cancer who died in ICUs or hospitals experienced more physical and emotional distress at the end of life.
More from content
-
Paul G. Rogers Memorial Scholars Program
May 20, 2023
The Paul G. Rogers Memorial Scholars Program The Paul G. Rogers Memorial Health Policy Analysis and Advocacy Scholars Program is an unpaid internship…Read more -
Projected 8.5 Percent Increase in Employer Healthcare Costs in 2012
May 20, 2023
News Type: News Article May 25, 2011 Issue Areas: Cost, Economic Impacts, Trends Employers can expect to see an 8.5 percent increase in…Read more -
Public Health Advocacy Organization Opposes Health Spending Cuts
May 20, 2023
News Type: News Article Article: Trust For America’s Health Opposes H.R. 1 March 2, 2011 Issue Areas: Delivery System Reforms, Financing, Policy Implementation, Prevention…Read more -
Repeal, A Critical Step Backward on Cost Control
May 20, 2023
News Type: News Article January 20, 2011 Issue Areas: Cost, Coverage, Delivery System Reforms, Disparities, Drug and Device Cost Containment, Economic Impacts, Financing, Innovation, Insurance, Policy Implementation, Prevention & Wellness, Quality &…Read more